A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma

Journal of Veterinary Internal Medicine

Volumn 10, Issue 6, 1996, Pages 372-375

  Moore, Antony S ^a,b   Cotter, Susan M ^a   Frimberger, Angela E ^a   Wood, Carrie A ^a   Rand, William M ^b   L'Heureux, Deborah A ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COP PROTOCOL 2; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LYMPHOMA; MALE; RANDOMIZED CONTROLLED TRIAL; REMISSION; STANDARD; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAT DISEASES; CATS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; LYMPHOMA; MALE; PREDNISONE; REMISSION INDUCTION; TIME FACTORS; VINCRISTINE;

EID: 0030281493     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.1996.tb02083.x     Document Type: Review

References (12)

1. Moulton JE, Harvey JW. Tumors of the lymphoid and hematopoietic tissues. In: Moulton JE, ed. Tumors in Domestic Animals, 3rd ed. Berkeley, CA: University of California; 1990:231-307.
2. Cotter S. Treatment of lymphoma and leukemia with cyclophosphamide, vincristine and prednisone: II treatment of cats. J Am Animal Hosp 1983;19:166-172.
3. Mooney S, Hayes A, MacEwen E, et al. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981). J Am Vet Med Assoc 1989;194:696-699.
4. Cotter S, Essex M, McLane M, et al. Chemotherapy and passive immunotherapy in naturally occurring feline mediastinal lymphoma. In: Hardy WD Jr, et al., eds. Feline Leukemia Virus. New York, NY: Elsevier North Holland; 1980:219-225.
5. Jeglum K, Whereat A, Young K. Chemotherapy of lymphoma in 75 cats. J Am Vet Med Assoc 1987;190:174-178.
6. Carter R, Harris C, Withrow S, et al. Chemotherapy of canine lymphoma with histopathological correlation: Doxorubicin alone compared to COP as first treatment regimen. J Am Anim Hosp Assoc 1987;23:587-596.
7. Postorino N, Susaneck S, Withrow S, et al. Single agent therapy with Adriamycin for canine lymphosarcoma. J Am Anim Hosp Assoc 1989;25:221-225.
8. Gray K, Raulston G, Gleiser C, et al. Histologic classification as an indicator of therapeutic response in malignant lymphoma in dogs. J Am Vet Med Assoc 1984;184:814-817.
9. Moore AS, Ruslander D, Cotter SM, et al. Efficacy and toxicoses associated with oral idarubicin administration in cats with neoplasia. J Am Vet Med Assoc, 1995;206:1550-1554.
10. Mooney S, Hayes A. Lymphoma in the cat: An approach to diagnosis and malignant. Semin Vet Med Surg (Small Anim) 1986;1: 51-57.
11. Mahony O, Moore AS, Cotter SM, et al. Alimentary lymphoma in cats: 28 cases (1988 to 1993). J Am Vet Med Assoc, 1995;207:1593-1598.
12. Meyers CE Jr, Chabner BA. Anthracyclines. In: Chabner BA, Collins JM, eds. Cancer Chemotherapy: Principles and Practice. Philadelphia, PA: JB Lippincott; 1990:356-381.